# Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting Conditions

> **NCT01149746** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tamsulosin
- **DRUG:** Tamsulosin

## Key facts

- **NCT ID:** NCT01149746
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2010-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01149746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01149746, "Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting Conditions". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01149746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*